INM 8-K 2026-11-03

InMed Pharmaceuticals Inc. (INM) 8-K dated 2026-11-03 — accession 0001062993-26-005723.

InMed Pharmaceuticals Inc. (INM) is a drug manufacturers - specialty & generic company listed on US.

InMed Pharmaceuticals Inc. filed a 8-K on 2026-11-03. Accession 0001062993-26-005723.

This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. Revenue was up 7.5% from 2024-06-30 to 2025-06-30. INM currently screens at market cap $5.2M.

Not investment advice. The INM SEC hub lists recent forms. The stock page is the research view.